183 related articles for article (PubMed ID: 14508721)
1. COX-2 inhibitors in oncology.
Haller DG
Semin Oncol; 2003 Aug; 30(4 Suppl 12):2-8. PubMed ID: 14508721
[No Abstract] [Full Text] [Related]
2. COX-2 inhibitors: cancer trials test new uses for pain drug.
Michalowski J
J Natl Cancer Inst; 2002 Feb; 94(4):248-9. PubMed ID: 11854385
[No Abstract] [Full Text] [Related]
3. Celecoxib with chemotherapy in colorectal cancer.
Blanke CD
Oncology (Williston Park); 2002 Apr; 16(4 Suppl 3):17-21. PubMed ID: 12014863
[TBL] [Abstract][Full Text] [Related]
4. Translational medicine: targetting cyclo-oxygenase isozymes to prevent cancer.
Sharma RA
QJM; 2002 May; 95(5):267-73. PubMed ID: 11978897
[No Abstract] [Full Text] [Related]
5. Selective COX-2 inhibitors as chemopreventive and therapeutic agents.
Grossman HB
Drugs Today (Barc); 2003 Mar; 39(3):203-12. PubMed ID: 12730704
[TBL] [Abstract][Full Text] [Related]
6. Prevention of colorectal cancer: tumor progression, chemoprevention, and COX-2 inhibition.
Bresalier RS
Gastroenterology; 2000 Jul; 119(1):267-8. PubMed ID: 10889181
[No Abstract] [Full Text] [Related]
7. Chemoprevention comes to clinical practice: COX-2 inhibition in familial adenomatous polyposis.
Bresalier RS
Gastroenterology; 2000 Dec; 119(6):1797-8. PubMed ID: 11113106
[No Abstract] [Full Text] [Related]
8. Combination of a COX-2 inhibitor with radiotherapy or radiochemotherapy in the treatment of thoracic cancer.
Liao Z; Milas L; Komaki R; Stevens C; Cox JD
Am J Clin Oncol; 2003 Aug; 26(4):S85-91. PubMed ID: 12902863
[TBL] [Abstract][Full Text] [Related]
9. COX-2-Selective NSAIDs: new and improved?
Lichtenstein DR; Wolfe MM
JAMA; 2000 Sep; 284(10):1297-9. PubMed ID: 10980759
[No Abstract] [Full Text] [Related]
10. Coming: a review of second-generation nonsteroidal anti-inflammatory drugs.
Housholder GT; Chan JT
J Gt Houst Dent Soc; 1997 Mar; 68(8):13-6. PubMed ID: 9594801
[No Abstract] [Full Text] [Related]
11. Chemopreventive effect of celecoxib and expression of cyclooxygenase-1 and cyclooxygenase-2 on chemically-induced rat mammary tumours.
Jang TJ; Jung HG; Jung KH; O MK
Int J Exp Pathol; 2002 Aug; 83(4):173-82. PubMed ID: 12485462
[TBL] [Abstract][Full Text] [Related]
12. Targeting cyclooxygenase-2 in human neoplasia: rationale and promise.
Dannenberg AJ; Subbaramaiah K
Cancer Cell; 2003 Dec; 4(6):431-6. PubMed ID: 14706335
[No Abstract] [Full Text] [Related]
13. COX-2-selective inhibitors: clinical relevance in surgical and acute pain.
Rowbotham DJ
Eur J Anaesthesiol Suppl; 2002; 25():11-20. PubMed ID: 12449673
[No Abstract] [Full Text] [Related]
14. The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis.
Jacoby RF; Seibert K; Cole CE; Kelloff G; Lubet RA
Cancer Res; 2000 Sep; 60(18):5040-4. PubMed ID: 11016626
[TBL] [Abstract][Full Text] [Related]
15. Update on clinical developments with celecoxib, a new specific COX-2 inhibitor: what can we expect?
Geis GS
J Rheumatol Suppl; 1999 Apr; 56():31-6. PubMed ID: 10225538
[TBL] [Abstract][Full Text] [Related]
16. [Topical pharmacology. COX-2 inhibitors].
Heinzl S
Med Monatsschr Pharm; 1999 Oct; 22(10):298-304. PubMed ID: 10540801
[No Abstract] [Full Text] [Related]
17. The new NSAIDs: cox-2 inhibitors.
Capriotti T
Medsurg Nurs; 2000 Dec; 9(6):313-7. PubMed ID: 11904867
[No Abstract] [Full Text] [Related]
18. [Thinking about the specific cyclooxygenase-2 inhibitors since its recommendation].
Shi G
Zhonghua Nei Ke Za Zhi; 2001 Sep; 40(9):579-80. PubMed ID: 11758234
[No Abstract] [Full Text] [Related]
19. Are selective COX 2 inhibitors superior to traditional non steroidal anti-inflammatory drugs?
Jüni P; Rutjes AW; Dieppe PA
BMJ; 2002 Jun; 324(7349):1287-8. PubMed ID: 12039807
[No Abstract] [Full Text] [Related]
20. Celecoxib, a selective cyclooxygenase-2 inhibitor for the treatment of rheumatoid arthritis and osteoarthritis.
Goldenberg MM
Clin Ther; 1999 Sep; 21(9):1497-513; discussion 1427-8. PubMed ID: 10509845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]